A Study to Demonstrate the Efficacy and Safety of Motilitone®
NCT01817465 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 389
Last updated 2015-01-27
Summary
This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-centers, double blind, randomization, parallel. The subjects will receive Motilitone® or/and Pantoline®.
Conditions
- Functional Dyspepsia
Interventions
- DRUG
-
Motilitone ®
- DRUG
-
Pantoline®
- DRUG
-
Motilitone® and Pantoline®
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Myung Kyu Choi, M.D., Ph.D. · The Catholic University of Korea
-
Kyu Chan Huh, M.D., Ph.D. · Konyang University Hospital
-
Sung Kook Kim, M.D., Ph.D. · Kyungpook National University Hospital
-
Kyung Sik Park, M.D., Ph.D. · Keimyung University Dongsan Medical Center
-
Joong Gu Gweon, M.D.,Ph.D. · Daegu Catholic University Medical Center
-
Geun Am Song, M.D., Ph.D. · Busan National University Hospital
-
Soo Jin Hong, M.D., Ph.D. · Soonchunhyang University Hospital
-
Na Young Kim, M.D., Ph.D. · Seoul National University Bundang Hospital
-
Jung Il Son, M.D., Ph.D. · Kangbuk Samsung Hospital
-
Poong Yul Lee, M.D., Ph.D. · Samsung Medical Center
-
Joon Sung Lee, M.D., Ph.D. · Soonchunhyang University Hospital
-
Hoon Yong Jung, M.D., Ph.D. · Asan Medical Center
-
Hyo Jin Park, M.D., Ph.D. · Gangnam Severance Hospital
-
Yong Chan Lee, M.D., Ph.D. · Severance Hospital
-
Suk Chae Choi, M.D., Ph.D. · Wonkwang Medical Center
-
Hye Kyung Jung, M.D., Ph.D. · Iwha Womans Unversity Mokdong Hospital
-
Sam Ryong Ji, M.D., Ph.D. · Inje University
-
Jong Sun Ryu, M.D., Ph.D. · Chonnam National University Hospital
-
Oh Young Lee, M.D., Ph.D. · Hanyang University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
NCT03184402 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study
NCT02460601 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
NCT03024086 ·Status: COMPLETED ·Phase: PHASE3
-
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
NCT03617016 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia
NCT01232114 ·Status: UNKNOWN
-
The Comparative Analysis Between Motilitone and Gasmotin for the Symptom Relief in Gallstone Patients With Functional Dyspepsia
NCT04350346 ·Status: UNKNOWN ·Phase: NA
-
The Use of Domperidone for Gastroparesis
NCT01378884 ·Status: WITHDRAWN ·Phase: PHASE3
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia
NCT02604576 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules
NCT03149393 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis
NCT03173183 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Multiple Medications on the Incidence of Organic Dyspepsia
NCT05524675 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
NCT01817556 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Aolanti Weikang Tablets in Healthy Volunteers
NCT03358485 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
NCT02567578 ·Status: TERMINATED ·Phase: PHASE2
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function
NCT05071781 ·Status: COMPLETED ·Phase: PHASE4
-
Budesonide as a Treatment for Functional Dyspepsia
NCT06841406 ·Status: RECRUITING ·Phase: PHASE4
-
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
NCT01394198 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia
NCT05199441 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA